Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Canna-V-Cell Sciences (OP: CNVCF )

0.1600 -0.0288 (-15.25%)
Streaming Delayed Price Updated: 1:34 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Canna-V-Cell Sciences

< Previous 1 2 Next >
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results
FY 2023 Revenue Increased 2.3x to $12.7 Million USDThe Company expects Q1 2024 Revenue to be in the range of... 
Via Newsfile
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity
80,000 Square Foot (7,500 Square Meter) Property includes 12 GMP Clean Rooms, Laboratory and Office space, and can accommodate expanded... 
Via Newsfile
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 21, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 14, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 13, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the... 
Via Newsfile
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 29, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
Via Newsfile
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 26, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 15, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 12, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
Life Science Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
BioHarvest Sciences to Present at the Life Sciences Investor Forum December 14th
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Life Science Investor Forum Agenda Announced for December 14th, 2023
From Virtual Investor Conferences
Via GlobeNewswire
BioHarvest Sciences Inc. Announces $11.78M Raised in First Tranche of $13.5M Private Placement
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 30, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
Health Canada Grants BioHarvest Sciences License for VINIA Sales in Canada
Significant milestone marking the beginning of VINIA® geographical expansion beyond Israel and the US Further validation from global health authorities... 
Via Newsfile
BioHarvest Announces August 2023 U.S. VINIA Sales Exceeded USD $1Million
Significant milestone demonstrating sales momentum of VINIA®Further validation of the Botanical Synthesis Technology PlatformStrong justification of the Direct-to-Consumer sales strategyVancouver,... 
Via Newsfile
BioHarvest Sciences Reports Q2 2023 Results Demonstrating Continued Growth Momentum
Q2 VINIA® revenues of USD 2.75M represent growth of 228% compared to Q2 2022 and 27% compared to Q1 2023... 
Via Newsfile
BioHarvest Sciences to Host Virtual Shareholder Presentation September 6, 2023
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 24, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the... 
Via Newsfile
BioHarvest Sciences Inc. Announces Closing of Private Placement of Convertible Notes
This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.Vancouver,... 
Via Newsfile
BioHarvest Chief Medical Officer Shares Personal Journey at Collision Conference
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 30, 2023) - Dr. Brian Cornblatt, the Chief Medical Officer of... 
Via Newsfile
BioHarvest Sciences Chief Medical Officer to Speak at Collision Conference in Toronto
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
BioHarvest Participates at Major Jefferies Investment Conference Tuesday June 27
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 26, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
BioHarvest Unveils New Consumption Categories for its Flagship Product VINIA
Celebrating two years since launch of VINIA® into the USNew categories have potential for significant impact on financial results starting... 
Via Newsfile
BioHarvest Sciences Adds Renowned Scientist to Scientific Advisory Board
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 6, 2023) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) announces that... 
Via Newsfile
BioHarvest Reports Q1 2023 Results Demonstrating Strong Year Over Year Growth
VINIA® revenues grew 209% compared to Q1 2022 to reach USD 2.2 MReiterating guidance for year-on-year revenue growth of 3... 
Via Newsfile
Topics Economy
Exposures Supply Chain
BioHarvest Adds over 25,000 US Customers in Last 365 Days and Congratulates NFL "Team VINIA" Prospects on Draft Day Success
4.7/5 average rating based on over 2000 verified online customer reviews Over 25,000 new US customers and 50,000+ total orders... 
Via Newsfile
BioHarvest Sciences Named Honorable Mention in Wellness Category of Fast Company's 2023 World Changing Ideas Awards
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 3, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) is... 
Via Newsfile
BioHarvest Sciences Contributing VINIA to NFL Training Camp Preparation
VINIA will be provided to over 140 NFL athletes preparing for the 2023 NFL SeasonFive House of Athlete Combine Trainees... 
Via Newsfile
BioHarvest Sciences to Host Virtual Shareholder Presentation May 4, 2pm ET
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 26, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB:CNVCF) ("BioHarvest" or the... 
Via Newsfile
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.